Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eastern Bankshares Inc. Common Stock (EBC) vs Stryker Corporation (SYK) Price & Performance

Eastern Bankshares Inc. Common StockTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Eastern Bankshares Inc. Common Stock vs Stryker Corporation — how do they compare? Eastern Bankshares Inc. Common Stock trades at $20.77 (market cap $4.79B), while Stryker Corporation trades at $285 (market cap $108.38B). The key difference: Stryker Corporation is far larger — about 22.6× Eastern Bankshares Inc. Common Stock's market cap, and Eastern Bankshares Inc. Common Stock pays the higher dividend (2.67%). Which is the better fit depends on your goals — on Pluang, investors hold Eastern Bankshares Inc. Common Stock for 0 Days and Stryker Corporation for 22 Days on average.

EBCSYK
Market Cap
$4.79B$108.38B
Volume
1,740,7162,068,363
Sector
FinancialsHealth
52-Week High
$23.65$388.35
52-Week Low
$16.73$269.75
Typical Hold Time
0 Days22 Days
Enterprise Value
$5.07B$119.84B
Dividend Yield
2.67%1.25%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eastern Bankshares Inc. Common Stock

Eastern Bankshares (EBC) trades at $20.96, down 0.85% on the day, with a neutral technical signal. The stock shows strong fundamentals, including a P/E of 11.71, net income margin of 33.47%, and recent Q2 2026 EPS beat. Analyst consensus is bullish with a $25.60 price target. Recent news highlights institutional buying and upcoming Q3 2026 earnings.

The outlook is positive given solid profitability, attractive valuation, and analyst support. Key risks include integration challenges from recent acquisitions and interest rate sensitivity. Upside potential exists if earnings momentum continues, but investors should monitor net cash flow trends and competitive pressures.

Stryker Corporation

Stryker (SYK) trades at $282.63, showing minimal daily movement. The stock exhibits a neutral technical stance with mixed moving averages and oscillators. Fundamentally, SYK maintains strong profitability with a 14.43% net income margin and 16.51% ROE, though a P/E of 29.28 suggests a premium valuation. Recent news highlights ongoing legal scrutiny over a manufacturing issue disclosed in September 2026, which caused a significant price drop. Q3 2026 earnings are anticipated on October 29, 2026, following a mix of beats and misses in prior quarters.

The outlook for SYK is cautiously optimistic, supported by analyst consensus with a $365.89 price target and no sell ratings. Investment appeal lies in its solid cash flow and market position, but risks include legal investigations and persistent operational challenges. The stock's near-term direction will likely hinge on Q3 earnings results and clarity on the manufacturing issue resolution.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EBC
100% Buy0% Sell
Avg holding period · 0 Days
SYK
100% Buy0% Sell
Avg holding period · 22 Days

Top news

Latest headlines on both assets

About Eastern Bankshares Inc. Common Stock

Eastern Bankshares, Inc. is the holding company for Eastern Bank, a Massachusetts-based bank operating more than 125 branches across eastern Massachusetts, southern and coastal New Hampshire, and Rhode Island, offering consumer and business banking along with wealth management through its Cambridge Trust divisions.

Read more on EBC →

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK →